Menu
 
Research menu
Jump to menu

Publications:  Dr Tanya Soliman

Parker PJ, Lockwood N, Davis K, Kelly JR, Soliman TN, Pardo AL, Marshall JJT, Redmond JM et al.(2020). A cancer-associated, genome protective programme engaging PKCε. Advances in Biological Regulation vol. 78,
10.1016/j.jbior.2020.100759
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68410
Kelly JR, Martini S, Brownlow N, Joshi D, Federico S, Jamshidi S, Kjaer S, Lockwood N et al.(2020). Author Correction: The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition (Nature Communications, (2020), 11, 1, (1396), 10.1038/s41467-020-15163-6). Nature Communications vol. 11, (1)
10.1038/s41467-020-16468-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67376
Kelly JR, Martini S, Brownlow N, Joshi D, Federico S, Jamshidi S, Kjaer S, Lockwood N et al.(2020). The Aurora B specificity switch is required to protect from non-disjunction at the metaphase/anaphase transition. Nature Communications vol. 11, (1)
10.1038/s41467-020-15163-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67375
Parker PJ, Brown SJ, Calleja V, Chakravarty P, Cobbaut M, Linch M, Marshall JJT, Martini S et al.(2020). Equivocal, explicit and emergent actions of PKC isoforms in cancer. Nature Reviews Cancer
10.1038/s41568-020-00310-4
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68407
Mcclelland S, Tamura N, Shaikh N, Muliaditan D, Soliman T, McGuinness J, Maniati E, Moralli D et al.(2020). Specific mechanisms of chromosomal instability indicate therapeutic sensitivities in high-grade serous ovarian carcinoma. Cancer Research
10.1158/0008-5472.CAN-19-0852
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67516
Deiss K, Lockwood N, Howell M, Segeren HA, Saunders RE, Chakravarty P, Soliman TN, Martini S et al.(2019). A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest. Nucleic Acids Research vol. 47, (6) 2906-2921.
10.1093/nar/gky1295
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68411
Claus J, Patel G, Autore F, Colomba A, Weitsman G, Soliman TN, Roberts S, Zanetti-Domingues LC et al.(2018). Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface. eLife vol. 7,
10.7554/eLife.32271
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67502
Martini S, Soliman T, Gobbi G, Mirandola P, Carubbi C, Masselli E, Pozzi G, Parker PJ et al.(2018). PKCϵ controls mitotic progression by regulating centrosome migration and mitotic spindle assembly. Molecular Cancer Research vol. 16, (1) 3-15.
10.1158/1541-7786.MCR-17-0244
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68413
Pike T, Brownlow N, Kjaer S, Carlton J, Parker PJ(2016). PKCϵ switches Aurora B specificity to exit the abscission checkpoint. Nature Communications vol. 7,
10.1038/ncomms13853
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67504
Brownlow N, Pike T, Crossland V, Claus J, Parker P(2014). Regulation of the cytokinesis cleavage furrow by PKCε. Biochemical Society Transactions vol. 42, (6) 1534-1537.
10.1042/BST20140240
Brownlow N, Pike T, Zicha D, Collinson L, Parker PJ(2014). Mitotic catenation is monitored and resolved by a PKC-regulated pathway. Nature Communications vol. 5,
10.1038/ncomms6685
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68408
Pike T, Widberg C, Goodall A, Payne E, Giles N, Hancock J, Gabrielli B(2013). Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells. Cellular Signalling vol. 25, (6) 1423-1428.
10.1016/j.cellsig.2013.03.014
Astuti P, Pike T, Widberg C, Payne E, Harding A, Hancock J, Gabrielli B(2009). MAPK pathway activation delays G<inf>2</inf>/M progression by destabilizing Cdc25B. Journal of Biological Chemistry vol. 284, (49) 33781-33788.
10.1074/jbc.M109.027516
Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA, Pike T et al.(2008). Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes and Cancer vol. 47, (6) 449-460.
10.1002/gcc.20552
Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VLJ, Pike T, Simms LA, Young J et al.(2006). High Prevalence of Sessile Serrated Adenomas With BRAF Mutations: A Prospective Study of Patients Undergoing Colonoscopy. Gastroenterology vol. 131, (5) 1400-1407.
10.1053/j.gastro.2006.08.038
Return to top